Trials / Conditions / Streptococcus Pneumoniae Infection

Streptococcus Pneumoniae Infection

12 registered clinical trials studyying Streptococcus Pneumoniae Infection — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Curian S. Pneumo/Legionella Assay Beta Clinical Trial Protocol NCT05681156	Meridian Bioscience, Inc.	—
Active Not Recruiting	Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants NCT05759520	Fosun Adgenvax Biopharmaceutical Co.,Ltd.	Phase 3
Completed	Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve V NCT05060146	Centre Hospitalier Universitaire de Nīmes	N/A
Completed	A Controlled Human Pneumococcal Infection Model (PIM) Study NCT05361499	Radboud University Medical Center	N/A
Not Yet Recruiting	Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus NCT05017519	Mackay Memorial Hospital	—
Unknown	Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chr NCT04944719	Universidad de la Sabana	—
Completed	The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Inf NCT03489018	London School of Hygiene and Tropical Medicine	Phase 4
Completed	Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger NCT03696303	University of Colorado, Denver	—
Completed	CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study NCT03384589	University of British Columbia	Phase 2 / Phase 3
Unknown	Understanding Pneumococcal Carriage and Disease 2017-2020 NCT03102840	University of Oxford	—
Completed	Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004) NCT02037984	Merck Sharp & Dohme LLC	Phase 1 / Phase 2
Completed	Effect of Two Versus Three Pneumococcal Conjugate Vaccinations NCT00189020	UMC Utrecht	Phase 3